Frequency of heterozygous Parkin mutations in healthy subjects: Need for careful prospective follow-up examination of mutation carriers

Parkinsonism and Related Disorders

Volumn 15, Issue 6, 2009, Pages 425-429

  Brüggemann, Norbert ^a   Mitterer, Manfred ^b   Lanthaler, Andrea J ^b   Djarmati, Ana ^a   Hagenah, Johann ^a   Wiegers, Karin ^a   Winkler, Susen ^a   Pawlack, Heike ^a   Lohnau, Thora ^a   Pramstaller, Peter P ^c,d   Klein, Christine ^a   Lohmann, Katja ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b General Hospital Merano   (Italy)

^c CENTRAL HOSPITAL OF BOLZANO   (Italy)

^d INSTITUTE FOR RENEWABLE ENERGY   (Italy)

Author keywords

Controls; Heterozygous mutation; Hyperechogenicity; Parkin; Subtle signs

Indexed keywords

PARKIN;

ADULT; ARTICLE; CONTROLLED STUDY; EUROPE; EXON; FEMALE; FOLLOW UP; FRAMESHIFT MUTATION; GENE DOSAGE; GENE MUTATION; GERMANY; HETEROZYGOSITY; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; MALE; MISSENSE MUTATION; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROTEIN STRUCTURE;

ADULT; AGED; AGED, 80 AND OVER; BRAIN STEM; EXONS; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GERMANY; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; PARKINSON DISEASE; UBIQUITIN-PROTEIN LIGASES; YOUNG ADULT;

EID: 67549146854     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2008.11.014     Document Type: Article

References (21)

1. Klein C., Lohmann-Hedrich K., Rogaeva E., Schlossmacher M.G., and Lang A.E. Deciphering the role of heterozygous mutations in genes associated with parkinsonism. Lancet Neurol 6 (2007) 652-662
2. Hedrich K., Eskelson C., Wilmot B., Marder K., Harris J., Garrels J., et al. Distribution, type, and origin of Parkin mutations: review and case studies. Mov Disord 19 (2004) 1146-1157
3. Okubadejo N., Britton A., Crews C., Akinyemi R., Hardy J., Singleton A., et al. Analysis of Nigerians with apparently sporadic Parkinson disease for mutations in LRRK2, PRKN and ATXN3. PLoS ONE 3 (2008) e3421
4. Lesage S., Lohmann E., Tison F., Durif F., Durr A., and Brice A. Rare heterozygous parkin variants in French early-onset Parkinson disease patients and controls. J Med Genet 45 (2008) 43-46
5. Lincoln S.J., Maraganore D.M., Lesnick T.G., Bounds R., de Andrade M., Bower J.H., et al. Parkin variants in North American Parkinson's disease: cases and controls. Mov Disord 18 (2003) 1306-1311
6. Kay D.M., Moran D., Moses L., Poorkaj P., Zabetian C.P., Nutt J., et al. Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients. Ann Neurol 61 (2007) 47-54
7. Clark L.N., Afridi S., Karlins E., Wang Y., Mejia-Santana H., Harris J., et al. Case-control study of the parkin gene in early-onset Parkinson disease. Arch Neurol 63 (2006) 548-552
8. Wang Y., Clark L.N., Louis E.D., Mejia-Santana H., Harris J., Cote L.J., et al. Risk of Parkinson disease in carriers of parkin mutations: estimation using the kin-cohort method. Arch Neurol 65 (2008) 467-474
9. Hedrich K., Kann M., Lanthaler A.J., Dalski A., Eskelson C., Landt O., et al. The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism. Hum Mol Genet 10 (2001) 1649-1656
10. Hagenah J.M., König I.R., Becker B., Hilker R., Kasten M., Hedrich K., et al. Substantia nigra hyperechogenicity correlates with clinical status and number of Parkin mutated alleles. J Neurol 254 (2007) 1407-1413
11. Ng P.C., and Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 31 (2003) 3812-3814
12. Kann M., Jacobs H., Mohrmann K., Schumacher K., Hedrich K., Garrels J., et al. Role of parkin mutations in 111 community-based patients with early-onset parkinsonism. Ann Neurol 51 (2002) 621-625
13. Abou-Sleiman P.M., Muqit M.M., McDonald N.Q., Yang Y.X., Gandhi S., Healy D.G., et al. A heterozygous effect for PINK1 mutations in Parkinson's disease?. Ann Neurol 60 (2006) 414-419
14. Hedrich K., Hagenah J., Djarmati A., Hiller A., Lohnau T., Lasek K., et al. Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease: role of a single hit?. Arch Neurol 63 (2006) 833-838
15. Funayama M., Li Y., Tsoi T.H., Lam C.W., Ohi T., Yazawa S., et al. Familial Parkinsonism with digenic parkin and PINK1 mutations. Mov Disord 23 (2008) 1461-1465
16. Lohmann E., Periquet M., Bonifati V., Wood N.W., De Michele G., Bonnet A.M., et al. How much phenotypic variation can be attributed to parkin genotype?. Ann Neurol 54 (2003) 176-185
17. Cookson M.R., Lockhart P.J., McLendon C., O'Farrell C., Schlossmacher M., and Farrer M.J. RING finger 1 mutations in Parkin produce altered localization of the protein. Hum Mol Genet 12 (2003) 2957-2965
18. Hampe C., Ardila-Osorio H., Fournier M., Brice A., and Corti O. Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity. Hum Mol Genet 15 (2006) 2059-2075
19. Bertoli-Avella A.M., Giroud-Benitez J.L., Akyol A., Barbosa E., Schaap O., van der Linde H.C., et al. Novel parkin mutations detected in patients with early-onset Parkinson's disease. Mov Disord 20 (2005) 424-431
20. Schlitter A.M., Kurz M., Larsen J.P., Woitalla D., Muller T., Epplen J.T., et al. Parkin gene variations in late-onset Parkinson's disease: comparison between Norwegian and German cohorts. Acta Neurol Scand 113 (2006) 9-13
21. Poorkaj P., Nutt J.G., James D., Gancher S., Bird T.D., Steinbart E., et al. Parkin mutation analysis in clinic patients with early-onset Parkinson [corrected] disease. Am J Med Genet A 129A (2004) 44-50